<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>1782361</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:660.6</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>Optimization of serum-free fermentation processes for antibody production</title></titleInfo>


<note type="publicationStatus">published</note>



<name type="personal">
  <namePart type="given">Heino</namePart>
  <namePart type="family">Büntemeyer</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">10725</identifier></name>
<name type="personal">
  <namePart type="given">Dirk</namePart>
  <namePart type="family">Lütkemeyer</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">10736</identifier></name>
<name type="personal">
  <namePart type="given">Jürgen</namePart>
  <namePart type="family">Lehmann</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">10036</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">Serum free fermentation procedures of cell cultures have got a wide application in production of biochemicals. But, cells cultured in serum free media in general are more sensitive to changes in culture condition, especially to nutrient limitation. There are no substances from serum which can support the cells when conditions are changing. In this study special attention is directed to amino acid utilization of mouse hybridoma in batch, chemostat and perfusion fermentations. Detailed data are presented which show the considerable difference of amino acid consumption rates in different fermentation modes. Already, in batch mode there are differences of the two investigated mouse hybridoma cell lines, although they are derived from the same myeloma line. In chemostat running at a dilution rate representing maximal growth rate most of the consumption rates are significant higher than in batch. On the other hand, in perfusion mode the rates are lower than in batch. This indicates clearly the different conditions of the fermentation modes. Therefore, it is necessary to develop serum free processes under the desired production conditions. An accurate analysis of the process is strongly recommended.</abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="buentemeyer_10.pdf">https://pub.uni-bielefeld.de/download/1782361/2313812/buentemeyer_10.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>Springer Science and Business Media LLC</publisher><dateIssued encoding="w3cdtf">1991</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">ger</languageTerm>
</language>

<subject><topic>substrate utilization</topic><topic>serum-free medium</topic><topic>hybridoma</topic><topic>amino acid analysis</topic><topic>antibody production</topic>
</subject>


<relatedItem type="host"><titleInfo><title>Cytotechnology</title></titleInfo>
  <identifier type="issn">0920-9069</identifier>
  <identifier type="eIssn">1573-0778</identifier>
  <identifier type="MEDLINE">1367052</identifier>
  <identifier type="ISI">A1991FD52500006</identifier><identifier type="urn">urn:nbn:de:0070-pub-17823614</identifier><identifier type="doi">10.1007/BF00365534</identifier>
<part><detail type="volume"><number>5</number></detail><detail type="issue"><number>1</number></detail><extent unit="pages">57-67</extent>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Büntemeyer, H., Lütkemeyer, D. &amp;amp; Lehmann, J. (1991). Optimization of serum-free fermentation processes for antibody production. &lt;em&gt;Cytotechnology&lt;/em&gt;, &lt;em&gt;5&lt;/em&gt;(1), 57-67. Springer Science and Business Media LLC. doi:10.1007/BF00365534.&lt;/div&gt;</dgps>
<bio1>Büntemeyer H, Lütkemeyer D, Lehmann J (1991) &lt;br /&gt;Optimization of serum-free fermentation processes for antibody production.&lt;br /&gt;Cytotechnology 5(1): 57-67.</bio1>
<angewandte-chemie>H.  Büntemeyer, D.  Lütkemeyer, and J.  Lehmann, “Optimization of serum-free fermentation processes for antibody production”, &lt;em&gt;Cytotechnology&lt;/em&gt;, &lt;strong&gt;1991&lt;/strong&gt;, &lt;em&gt;5&lt;/em&gt;, 57-67.</angewandte-chemie>
<ama>Büntemeyer H, Lütkemeyer D, Lehmann J. Optimization of serum-free fermentation processes for antibody production. &lt;em&gt;Cytotechnology&lt;/em&gt;. 1991;5(1):57-67.</ama>
<lncs> Büntemeyer, H., Lütkemeyer, D., Lehmann, J.: Optimization of serum-free fermentation processes for antibody production. Cytotechnology. 5, 57-67 (1991).</lncs>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Büntemeyer, Heino, Lütkemeyer, Dirk, and Lehmann, Jürgen. 1991. “Optimization of serum-free fermentation processes for antibody production”. &lt;em&gt;Cytotechnology&lt;/em&gt; 5 (1): 57-67.&lt;/div&gt;</chicago>
<mla>Büntemeyer, Heino, Lütkemeyer, Dirk, and Lehmann, Jürgen. “Optimization of serum-free fermentation processes for antibody production”. &lt;em&gt;Cytotechnology&lt;/em&gt; 5.1 (1991): 57-67.</mla>
<frontiers>Büntemeyer, H., Lütkemeyer, D., and Lehmann, J. (1991). Optimization of serum-free fermentation processes for antibody production. &lt;em&gt;Cytotechnology&lt;/em&gt; 5, 57-67.</frontiers>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Büntemeyer, H., Lütkemeyer, D., &amp;amp; Lehmann, J. (1991). Optimization of serum-free fermentation processes for antibody production. &lt;em&gt;Cytotechnology&lt;/em&gt;, &lt;em&gt;5&lt;/em&gt;(1), 57-67. &lt;a href="https://doi.org/10.1007/BF00365534" target="_blank"&gt;https://doi.org/10.1007/BF00365534&lt;/a&gt;&lt;/div&gt;</apa_indent>
<wels>Büntemeyer, H.; Lütkemeyer, D.; Lehmann, J. (1991): Optimization of serum-free fermentation processes for antibody production &lt;em&gt;Cytotechnology&lt;/em&gt;,5:(1): 57-67.</wels>
<default>Büntemeyer H, Lütkemeyer D, Lehmann J (1991) &lt;br /&gt;&lt;em&gt;Cytotechnology&lt;/em&gt; 5(1): 57-67.</default>
<ieee> H. Büntemeyer, D. Lütkemeyer, and J. Lehmann, “Optimization of serum-free fermentation processes for antibody production”, &lt;em&gt;Cytotechnology&lt;/em&gt;,  vol. 5, 1991,  pp. 57-67.</ieee>
<harvard1>Büntemeyer, H., Lütkemeyer, D., &amp;amp; Lehmann, J., 1991. Optimization of serum-free fermentation processes for antibody production. &lt;em&gt;Cytotechnology&lt;/em&gt;, 5(1), p 57-67.</harvard1>
<apa>Büntemeyer, H., Lütkemeyer, D., &amp;amp; Lehmann, J. (1991). Optimization of serum-free fermentation processes for antibody production. &lt;em&gt;Cytotechnology&lt;/em&gt;, &lt;em&gt;5&lt;/em&gt;(1), 57-67. &lt;a href="https://doi.org/10.1007/BF00365534" target="_blank"&gt;https://doi.org/10.1007/BF00365534&lt;/a&gt;</apa>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>1782361</recordIdentifier><recordCreationDate encoding="w3cdtf">2018-07-24T12:58:10Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2018-07-24T12:58:10Z</recordChangeDate>
</recordInfo>
</mods>